Skip to content

Ranitidine and pantoprazole in prevention of ventilator associated pneumonia

Comparing the effect of Ranitidin and Pantoprazole on ventilator associated pneumonia (VAP) in trauma patients admitted in ICU of Be'sat hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201109234578N3
Enrollment
Unknown
Registered
2011-10-07
Start date
2011-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: pneumonia. Condition 2: pneumonia. Condition 3: pneumonia. Pneumonia due to Streptococcus pneumoniae Pneumonia due to Haemophilus influenzae Bacterial pneumonia, not elsewhere classified

Interventions

Intervention 1: In intervention group Pantoprazol 40 mg once a day will infuse till to end of patient admission. Intervention 2: In control group Ranitidine 50 mg twice a day will infuse till to end o
Prevention
In intervention group Pantoprazol 40 mg once a day will infuse till to end of patient admission
In control group Ranitidine 50 mg twice a day will infuse till to end of patient admission.

Sponsors

Hamedan University of Medical Sciences-vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion: Trauma patients undergoing mechanical ventilation for more than 48 hours, Age>18y? Admitted in ICU? APACHESCOREII25? History of corticosteroids or NSAIDs usage,Under mechanical ventilation less than 48 hours, Age<18y.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Ventilator associated pneumonia. Timepoint: daily. Method of measurement: 1- radiographic criteria(The presence of a new or progressive radiographic infiltrate or cavitation).2-clinical characteristics such as :fever , leukocytosis or leukopenia, and purulent secretions thar require Suction.3-Laboratory criteria:Positive throat &blood culture.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026